Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Sanofi (SNYNF) EBT Margin (2016 - 2025)

Historic EBT Margin for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to 49.31%.

  • Sanofi's EBT Margin rose 237300.0% to 49.31% in Q4 2025 from the same period last year, while for Dec 2025 it was 14.66%, marking a year-over-year decrease of 91600.0%. This contributed to the annual value of 16.74% for FY2025, which is 47900.0% down from last year.
  • Sanofi's EBT Margin amounted to 49.31% in Q4 2025, which was up 237300.0% from 24.66% recorded in Q3 2025.
  • In the past 5 years, Sanofi's EBT Margin ranged from a high of 103.46% in Q4 2022 and a low of 0.15% during Q4 2021
  • Its 5-year average for EBT Margin is 26.92%, with a median of 24.87% in 2025.
  • In the last 5 years, Sanofi's EBT Margin surged by 1036100bps in 2022 and then tumbled by -821700bps in 2023.
  • Over the past 5 years, Sanofi's EBT Margin (Quarter) stood at 0.15% in 2021, then skyrocketed by 70920bps to 103.46% in 2022, then plummeted by -79bps to 21.29% in 2023, then increased by 20bps to 25.58% in 2024, then soared by 93bps to 49.31% in 2025.
  • Its EBT Margin stands at 49.31% for Q4 2025, versus 24.66% for Q3 2025 and 8.28% for Q2 2025.